Abstract
Pharmacogenomics (PGx) as an emerging field, is poised to change the way we practice medicine and deliver health care by customizing drug therapies on the basis of each patient’s genetic makeup. A large volume of PGx data including information on relationships among drugs, genes, and single nucleotide polymorphisms (SNPs) has been accumulated. Normalized and integrated PGx information could facilitate revelation of hidden relationships among drug treatments, genomic variations, and phenotype traits to better support drug discovery and next generation of treatment. In this study, we constructed a normalized cancer based PGx network (CPN) by integrating cancer orientated PGx information from multiple well known PGx resources including the Pharmacogenomics Knowledge Base (PharmGKB), the FDA Pharmacogenomic Biomarkers in Drug Labeling, and the Catalog of Published Genome-Wide Association Studies. The ultimate goal of the CPN is to provide comprehensive cancer specific PGx information to support oncology related research, including cancer based drug discovery – drug repurposing. We have successfully demonstrated the capability of the CPN for drug repurposing by conducting two case studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hewett, M., Oliver, D.E., Rubin, D.L., et al.: PharmGKB: The pharmacogenetics knowledge base. Nucleic Acids Res. 30(1), 163–165 (2002)
Fu, B., Brennan, R., O’Sullivan, D.: A configurable translation-based cross-lingual ontology mapping system to adjust mapping outcomes. Web Semant. Sci. Serv. Agents World Wide Web 15, 15–36 (2012)
Lipson, D., Capelletti, M., Yelensky, R., et al.: Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat. Med. 18(3), 382–384 (2012)
Kreso, A., O’Brien, C.A., van Galen, P., et al.: Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 339(6119), 543–548 (2013)
Coulet, A., Smail-Tabbone M., Napoli, A., Devignes, M.D.: Suggested ontology for pharmacogenomics (SO-Pharm): Modular construction and preliminary testing. In: Proceedings of the Wokshop on Knowledge Systems in Bioinformatics, 29 October 2006
Dumontier, M., Villanueva-Rosales, N.: Towards pharmacogenomics knowledge discovery with the semantic web. Briefings Bioinform. 10(2), 153–163 (2009)
McGuinness, D.L., Van Harmelen, F.: OWL web ontology language overview. W3C recommendation, vol. 10, pp. 2004–03 (2004)
Coulet, A., Smaïl-Tabbone, M., Napoli, A., Devignes, M.-D.: Suggested ontology for pharmacogenomics (SO-Pharm): Modular construction and preliminary testing. Paper presented at: On the Move to Meaningful Internet Systems 2006: OTM 2006 Workshops2006
FDA Table of Pharmacogenomic Biomarkers in Drug Labeling. http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm. Accessed 14 Jan 2014
Kumar, S.K., Harding, J.: Ontology mapping using description logic and bridging axioms. Comput. Ind. 64, 19–28 (2012)
Frueh, F.W., Amur, S., Mummaneni, P., et al.: Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacother. J. Hum. Pharmacol. Drug Therapy 28(8), 992–998 (2008)
Hindorff, L.A., MJEBI, Morales, J., Junkins, H.A., Hall, P.N., Klemm, A.K., Manolio, T.A.: A Catalog of published genome-wide association studies. www.genome.gov/gwastudies. Accessed 14 Jan 2014
National Cancer Institute. http://www.cancer.gov/cancertopics/types/alphalist. Accessed 14 Jan 2014
The Pharmcogenomics Knowledgebase. http://www.pharmgkb.org/. Accessed 14 Jan 2014
Whetzel, P.L., Noy, N.F., Shah, N.H., et al.: BioPortal: Enhanced functionality via new Web services from the National Center for Biomedical Ontology to access and use ontologies in software applications. Nucleic Acids Res. 39(suppl 2), W541–W545 (2011)
National Center for Biomedical Ontology Rest Service. http://data.bioontology.org/documentation. Accessed 14 Jan 2014
Bos, L.: SNOMED-CT: The advanced terminology and coding system for eHealth. Med. Care Compunetics 3 121, 279 (2006)
Nelson, S.J., Zeng, K., Kilbourne, J., Powell, T., Moore, R.: Normalized names for clinical drugs: RxNorm at 6 years. J. Am. Med. Inform. Assoc. 18(4), 441–448 (2011)
Gardiner, K.: Human genome organization. Curr. Opin. Genet. Dev. 5(3), 315–322 (1995)
Sayers, E.W., Barrett, T., Benson, D.A., et al.: Database resources of the national center for biotechnology information. Nucleic Acids Res. 39(suppl 1), D38–D51 (2011)
Coletti, M.H., Bleich, H.L.: Medical subject headings used to search the biomedical literature. J. Am. Med. Inform. Assoc. 8(4), 317–323 (2001)
Bodenreider, O.: The unified medical language system (UMLS): Integrating biomedical terminology. Nucleic Acids Res. 32(suppl 1), D267–D270 (2004)
Saito, R., Smoot, M.E., Ono, K., et al.: A travel guide to Cytoscape plugins. Nat. Methods 9(11), 1069–1076 (2012)
Drugs@FDA. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/
Stankova, J., Shang, J., Rozen, R.: Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo. Clin. Cancer Res. 11(5), 2047–2052 (2005)
Elhawary, N.A., Hewedi, D., Arab, A., et al.: The MTHFR 677T allele may influence the severity and biochemical risk factors of Alzheimer’s disease in an Egyptian population. Dis. Mark. 35(5), 439–446 (2013)
Mansouri, L., Fekih-Mrissa, N., Klai, S., Mansour, M., Gritli, N., Mrissa, R.: Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer’s disease. Clin. Neurol. Neurosurg. 115(9), 1693–1696 (2013)
Shemesh, O.A., Spira, M.E.: Rescue of neurons from undergoing hallmark tau-induced Alzheimer’s disease cell pathologies by the antimitotic drug paclitaxel. Neurobiol. Dis. 43(1), 163–175 (2011)
Zhang, B., Maiti, A., Shively, S., et al.: Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl. Acad. Sci. U.S.A. 102(1), 227–231 (2005)
Drug label of Capecitabine in DailyMed. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8. Accessed 14 Jan 2014
Dong, N., Yu, J., Wang, C., et al.: Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine. J. Cancer Res. Clin. Oncol. 138(7), 1197–1203 (2012)
Androutsopoulos, V.P., Spyrou, I., Ploumidis, A., et al.: Expression Profile of CYP1A1 and CYP1B1 Enzymes in Colon and Bladder Tumors. PLoS ONE 8(12), e82487 (2013)
Patel, B., Forman, J., Fontana, J., Frazier, A., Pontes, E., Vaishampayan, U.: A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer. Int. J. Radiat. Oncol. Biol. Phys. 62(5), 1332–1338 (2005)
Michels, J., Barbour, S., Cavers, D., Chi, K.N.: Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: Case report and review of literature. Can. Urol. Assoc. J. 4(2), E55 (2010)
Wishart, D.S., Knox, C., Guo, A.C., et al.: DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34(suppl 1), D668–D672 (2006)
Kanehisa, M., Goto, S.: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27–30 (2000)
Page, L., Brin, S., Motwani, R., Winograd, T.: The PageRank citation ranking: Bringing order to the web (1999)
Zhu, Q., Freimuth, R.R., Pathak, J., Durski, M.J., Chute, C.G.: Disambiguation of PharmGKB drug-disease relations with NDF-RT and SPL. J. Biomed. Inform. 46(4), 690–696 (2013)
Jiang, G., Solbrig, H.R., Chute, C.G.: ADEpedia: a scalable and standardized knowledge base of Adverse Drug Events using semantic web technology. Paper presented at: AMIA Annual Symposium Proceedings (2011)
Hassanzadeh, O., Zhu Q, Freimuth, R., Boyce, R.: Extending the “Web of Drug Identity” with Knowledge Extracted from United States Product Labels. Submitted to AMIA Summit on Clinical Research Informatics (2013)
Chowdhury, G.G.: Natural language processing. Ann. Rev. Inf. Sci. Technol. 37(1), 51–89 (2003)
Shenoy, M.K., Shet, K., Acharya, D.U.: Semantic Web Technologies (2010)
Klyne, G., Carroll, J.J., McBride, B.: Resource description framework (RDF): Concepts and abstract syntax, W3C recommendation, p. 10 (2004)
Acknowledgement
This work was supported by the Pharmacogenomic Research Network (NIH/NIGMS-U19 GM61388).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this paper
Cite this paper
Wang, L., Liu, H., Chute, C.G., Zhu, Q. (2014). Cancer Based Pharmacogenomics Network for Drug Repurposing. In: Peng, WC., et al. Trends and Applications in Knowledge Discovery and Data Mining. PAKDD 2014. Lecture Notes in Computer Science(), vol 8643. Springer, Cham. https://doi.org/10.1007/978-3-319-13186-3_57
Download citation
DOI: https://doi.org/10.1007/978-3-319-13186-3_57
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13185-6
Online ISBN: 978-3-319-13186-3
eBook Packages: Computer ScienceComputer Science (R0)